Altre lingue Century Therapeutics, Inc.

Azioni

IPSC

US15673T1007

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 24/04/2024			Variaz. 5gg	Var. 1 gen.
2,96 ^USD	-5,43%		+4,23%	-10,84%

12/04	CENTURY THERAPEUTICS, INC. : da Piper Sandler è Buy	ZM
11/04	Syncona si accorda per la vendita di una partecipazione in una società partecipata per 7,4 milioni di sterline	AN

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Century Therapeutics to Present at Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit	24/04
Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit	23/04
Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit	23/04
Syncona agrees to sell stake in investee company for GBP7.4 million	11/04
Syncona to Sell Stake in Portfolio Company to Century Therapeutics	11/04
Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics	11/04
Century Therapeutics Announces Plans to Expand Clinical Development for Its Lead Program, CNTY-101	11/04
Century Therapeutics, Inc. acquired Clade Therapeutics, Inc. from Syncona Limited for $45 million..	11/04
Century Therapeutics, Inc. announced that it expects to receive $59.999982 million in funding from a group of investors	11/04
Century Therapeutics, Inc. agreed to acquire Clade Therapeutics, Inc. from Syncona Limited for $45 million.	11/04
Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research Annual Meeting	09/04
Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting	08/04
Century Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference	19/03
Sector Update: Health Care Stocks Retreating Late Afternoon	14/03
Century Therapeutics Shares Fall After Wider Loss, Lower Revenue in 2023	14/03
Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updates	14/03
Century Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	14/03
Century Therapeutics : Corporate Overview March 2024	11/03
Century Therapeutics Announces Six Upcoming Poster Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting	06/03
Century Therapeutics to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference	01/02

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Century Therapeutics, Inc.

Azioni

IPSC

US15673T1007

Altre lingue

Filtri